Searched for
MSD MERCK
MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufactur...27 Apr, 2021, 04.09 PM IST- Zydus Cadila acquires six brands from Merck IndiaThe acquired brands Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range had clocked sales of Rs 840 million in 2015.29 Dec, 2016, 12.03 AM IST
- Merck's Indian unit MSD may sell primary care drugs to focus on core brandsA sizeable part of the divestiture is from the primary care segment with a few Indian drug makers showing interest. Valuation is, however, ...15 Aug, 2016, 05.11 AM IST
- Hilleman Lab scouts for partners to develop low cost vaccinesHilleman said it is looking to tie up with vaccine specialty companies and government agencies to fund a Rs 300 project for developing some...30 Oct, 2015, 02.46 PM IST
- Hilleman Lab to invest Rs 300 crore to develop vaccines"We are spending around Rs 300 crore over the next 4-5 years to develop low-cost vaccines. We are developing vaccines to treat rotavirus, c...28 Oct, 2015, 08.13 PM IST
- MSD India to invest $10 million to reduce maternal mortalityMSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar ...14 May, 2013, 04.08 PM IST
- No interim relief to Merck against Glenmark’s diabetes genericsDelhi High Court has refused to bar Glenmark from selling the generic versions of anti-diabetic drugs manufactured by Merck Sharp & Dohme.06 Apr, 2013, 06.02 AM IST
- Merck scouts for marketing, licensing pacts with Indian cosMerck & Co, is looking at in-licensing and co-marketing arrangements with Indian pharma cos as it wants to realise its ambitions to become ...12 Mar, 2011, 04.43 AM IST
- Hilleman Lab to invest about Rs 650 cr to develop vaccinesAs per the company's estimates, it will take 2-4 years in research and development activities to come out with the new vaccine.24 Jan, 2011, 02.30 PM IST
- Merck, Ranbaxy drug development deal called offUS drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines, whi...06 Jan, 2011, 02.44 PM IST
- Relocation triggers exits at Merck armAround 50 executives quit MSD, the Indian arm of Merck & Co, in the past few months — most opted out due to the company’s decision to reloc...16 Nov, 2010, 01.57 AM IST
- Merck arm to sell cheap diabetes drugThis is perhaps one of the few instances where a drug is cheaper in India, as against its price in other developed markets. (Januvia is pri...21 Sep, 2009, 02.04 AM IST
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.10 Mar, 2009, 10.27 AM IST
- Merck buys Schering-Plough for $41 bn to access new drugsUS-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.10 Mar, 2009, 03.10 AM IST
- Merck subsidiary plans to launch patented drugsMerck Sharp & Dohme (MSD) Pharmaceuticals is betting big on India, an emerging market for its patented and first research-based vaccines an...30 Jul, 2008, 12.42 AM IST
- MSD Pharma launches JANUVIA for diabetic careDrug firm MSD Pharmaceuticals today launched its patent medicine under the brand name 'JANUVIA' in diabetic care segment and aims to tap fo...28 Apr, 2008, 05.46 PM IST
- US-based Merck to double workforce by year-endUS-based $25-billion Merck also plans to launch drugs targeted to Indian patients and introduce a competitive pricing pattern.22 Apr, 2008, 12.06 AM IST
Load More
